Cargando…

Kinetic Analysis of Dynamic (11)C-Acetate PET/CT Imaging as a Potential Method for Differentiation of Hepatocellular Carcinoma and Benign Liver Lesions

Objective: The kinetic analysis of (11)C-acetate PET provides more information than routine one time-point static imaging. This study aims to investigate the potential of dynamic (11)C-acetate hepatic PET imaging to improve the diagnosis of hepatocellular carcinoma (HCC) and benign liver lesions by...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huo, Li, Guo, Jinxia, Dang, Yonghong, Lv, Jinqiao, Zheng, Youjing, Li, Fang, Xie, Qingguo, Chen, Xiaoyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329501/ https://www.ncbi.nlm.nih.gov/pubmed/25699097 http://dx.doi.org/10.7150/thno.10760

Ejemplares similares

Application of Dual Phase Imaging of (11)C-Acetate Positron Emission Tomography on Differential Diagnosis of Small Hepatic Lesions
por: Huo, Li, et al.
Publicado: (2014)

Comparison among Reconstruction Algorithms for Quantitative Analysis of (11)C-Acetate Cardiac PET Imaging
por: Shi, Ximin, et al.
Publicado: (2018)

Comparison of (68)Ga-PSMA-11 PET/CT with (11)C-acetate PET/CT in re-staging of prostate cancer relapse
por: Regula, Naresh, et al.
Publicado: (2020)

PET Index of Bone Glucose Metabolism (PIBGM) Classification of PET/CT Data for Fever of Unknown Origin Diagnosis
por: Yang, Jian, et al.
Publicado: (2015)

A case of pulmonary benign metastasizing leiomyoma: clinicopathologic, immunohistochemical, and PET/CT analyses
por: Li, Qingguo, et al.
Publicado: (2019)

Myocardial tissue and metabolism characterization in men with alcohol consumption by cardiovascular magnetic resonance and 11C-acetate PET/CT
por: Liu, Shuai, et al.
Publicado: (2020)

Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical (11)C-acetate PET/CT
por: Strandberg, Sara, et al.
Publicado: (2018)

Carbon Flux as a Measure of Prostate Cancer Aggressiveness: [(11)C]-Acetate PET/CT
por: Regula, Naresh, et al.
Publicado: (2020)

Case Reports on the Differentiation of Malignant and Benign Intratracheal Lesions by (18)F-FDG PET/CT
por: Chun, Kyung-Ah
Publicado: (2015)

(11)C–acetate PET/CT: a potential alternative of transcranial biopsy for grading cerebral gliomas
por: Hatazawa, Jun
Publicado: (2018)

Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [(68)Ga]PSMA-11-PET and [(11)C]Acetate-PET
por: Sandgren, Kristina, et al.
Publicado: (2023)

PSA and PSA Kinetics Thresholds for the Presence of (68)Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer
por: Hoffmann, Manuela Andrea, et al.
Publicado: (2020)

Diagnostic value of (18)F-FDG PET/CT in discriminating between benign and malignant lesions of the ribs
por: Choi, Sunju, et al.
Publicado: (2022)

Can C-11 Acetate PET Be a Feasible Option for Assessing Non-Culprit Lesion in STEMI Patients?
por: Kong, Eunjung
Publicado: (2022)

(11)C-Acetate PET Imaging in Patients with Multiple Sclerosis
por: Takata, Kazushiro, et al.
Publicado: (2014)

(18)F Sodium Fluoride PET/CT in Patients with Prostate Cancer: Quantification of Normal Tissues, Benign Degenerative Lesions, and Malignant Lesions
por: Oldan, Jorge D., et al.
Publicado: (2016)

MRI and (11)C Acetate PET/CT for Prediction of Regional Lymph Node Metastasis in Newly Diagnosed Prostate Cancer
por: von Below, Catrin, et al.
Publicado: (2018)

Progression-free and overall survival in metastatic castration-resistant prostate cancer treated with abiraterone acetate can be predicted with serial C11-acetate PET/CT
por: Farnebo, Jacob, et al.
Publicado: (2016)

Differentiation of soft tissue and bone sarcomas from benign lesions utilizing (18)F-FDG PET/CT-derived parameters
por: Chen, Bo, et al.
Publicado: (2020)

FDG-PET/CT finding of benign metastasizing leiomyoma of the lung
por: Nakajo, Masatoyo, et al.
Publicado: (2012)

FDG PET/CT of Benign Psammomatous Meningioma Effacing the Medulla
por: Chuang, Tzyy-Ling, et al.
Publicado: (2021)

Incidental Breast Lesions Identified by (18)F-FDG PET/CT: Which Clinical Variables Differentiate between Benign and Malignant Breast Lesions?
por: Shin, Kyung Min, et al.
Publicado: (2015)

[(11)C]acetate PET as a tool for diagnosis of liver steatosis
por: Nejabat, Marzieh, et al.
Publicado: (2018)

Angiosarcoma of the Scalp: Metastatic Pulmonary Cystic Lesions Initially Misinterpreted as Benign Findings on 18F-FDG PET/CT
por: Andersen, Kim Francis, et al.
Publicado: (2015)

The value of [(11)C]-acetate PET and [(18)F]-FDG PET in hepatocellular carcinoma before and after treatment with transarterial chemoembolization and bevacizumab
por: Li, Shuren, et al.
Publicado: (2017)

Evaluation of (11)C-Acetate and (18) F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma
por: Territo, Paul R., et al.
Publicado: (2015)

A NIM PET/CT phantom for evaluating the PET image quality of micro-lesions and the performance parameters of CT
por: Lu, Shujie, et al.
Publicado: (2021)

Differentiation between Malignant and Benign Solitary Lesions in the Liver with (18)FDG PET/CT: Accuracy of Age-related Diagnostic Standard
por: Xia, Qian, et al.
Publicado: (2015)

The value of prebiopsy FDG-PET/CT in discriminating malignant from benign vertebral bone lesions in a predominantly oncologic population
por: Loudini, Naila, et al.
Publicado: (2020)

Astrocyte metabolism in multiple sclerosis investigated by 1-C-11 acetate PET
por: Kato, Hiroki, et al.
Publicado: (2020)

Benign pancreatic lesion on (18)F-FDG PET-MRI: A case report
por: Xiao, Yuqiang, et al.
Publicado: (2023)

A methodological investigation of healthy tissue, hepatocellular carcinoma, and other lesions with dynamic (68)Ga-FAPI-04 PET/CT imaging
por: Geist, Barbara Katharina, et al.
Publicado: (2021)

Kinetic patterns of benign and malignant breast lesions on contrast enhanced digital mammogram
por: Huang, Jer-Shyung, et al.
Publicado: (2020)

Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
por: Nakayama, Michihiro, et al.
Publicado: (2012)

The role of dual time point PET/CT for distinguishing malignant from benign focal (18)F-FDG uptake duodenal lesions
por: Sa, Ri, et al.
Publicado: (2018)

[(11)C]acetate PET/CT Visualizes Skeletal Muscle Exercise Participation, Impaired Function, and Recovery after Hip Arthroplasty; First Results
por: Buchegger, Franz, et al.
Publicado: (2010)

Benign mesocolon schwannoma in PET/CT and immunohistochemistry assessment: a case report
por: Kula, Zbigniew, et al.
Publicado: (2012)

Diagnostic value of (18)F-FDG-PET/CT in benign lung diseases
por: Ergonul, Ayse Gul, et al.
Publicado: (2018)

SAT-172 FDG PET/CT in Benign vs. Malignant Adrenocortical Tumors
por: He, Xin, et al.
Publicado: (2020)

FDG-PET/CT and CT Findings of a Benign Solitary Fibrous Tumor of the Kidney; Correlation with Pathology
por: Nakajima, Reiko, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ut21rlrql2rhrgjmekpv08d5ha